Abaloparatide Acetate is a synthetic parathyroid hormone-related protein (PTHrP) analog, classified as a peptide therapeutic agent indicated for the treatment of postmenopausal osteoporosis in women at… Read more
Abaloparatide Acetate is a synthetic parathyroid hormone-related protein (PTHrP) analog, classified as a peptide therapeutic agent indicated for the treatment of postmenopausal osteoporosis in women at high risk of fracture. By stimulating bone formation, this medication offers a critical alternative for patients who cannot tolerate traditional antiresorptive therapies. To support the rigorous analytical demands of pharmaceutical manufacturing and research, this category provides high-quality reference standards of the active pharmaceutical ingredient. Laboratories utilize these materials, along with associated impurities, metabolites, and stable isotope labelled compounds, for critical applications such as impurity profiling, method validation, and routine quality control. Accessing these well-characterized reference materials ensures accuracy during stability testing and regulatory compliance, allowing chemists to confidently identify and quantify trace components within complex drug matrices throughout the product development lifecycle.